FY2025 · ended Dec 31, 2025 · Revenue $16.37M, +304.0% YoY · Filed Apr 15, 2026
Foxo Technologies Inc. (FOXO) files with the SEC under industry code 8731, Services-Commercial Physical & Biological Research. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $16.4 million and a net loss of $12.4 million. Free cash flow was -$3.9 million. As of Jun 30, 2026 it held $58,409 in cash and investments and $3.4 million in total debt.
Revenue (TTM)
$17.86M
+44.0% vs year-ago TTM
Net income (TTM)
$-4.60M
+53.4% vs year-ago TTM
Operating cash flow (TTM)
$-428,038
+91.4% vs year-ago TTM
Free cash flow
$-3.93M
+83.5% vs prior year
EPS
—
Dividend per share
None
Shares outstanding
3.73B
+10313.7% vs prior year
Net cash
$-3.39M
as of Jun 30, 2026
Operating margin
-4.9%
FY 2026
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- FOXO (OTC), FOXOW (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- West Palm Beach, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1812360
- Former names
- Delwinds Insurance Acquisition Corp. (until Sep 15, 2022)
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- OmniAb, Inc. OABI
- NRC Health NRC
All 17 Services-Commercial Physical & Biological Research companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| Revenue | $16.4M | $4.1M | $145,291 | $511,000 |
| Operating income | -$10.3M | -$7.8M | -$22.2M | -$40.2M |
| Net income | -$12.4M | -$12.4M | -$26.5M | -$95.3M |
| Operating cash flow | -$3.9M | -$2.8M | -$6.6M | -$23.8M |
| Free cash flow | -$3.9M | — | — | -$23.9M |
| Total assets | $44.6M | $41.7M | $725,653 | $35.4M |
| Total liabilities | $33.5M | $36.4M | $14.8M | $28.7M |
| Stockholders' equity | $11.1M | $5.3M | -$14.1M | $6.7M |
| Cash and investments | $207,453 | $68,268 | $38,116 | $5.5M |
| Total debt | $3.7M | $4.0M | — | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 29, 2026 | Oct 25, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Aug 14, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 29, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Material agreement
|
Jul 27, 2026 | Jul 22, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 6, 2026 | Jul 6, 2026 |
All 538 Foxo Technologies Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.